The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 20,401–20,500 of 31,469
Hassan, A. A., Elshall, S., Erfan, A. A., et al. (2021) · Pediatric Research · doi:10.1038/s41390-021-01847-2 · Cited by 10
Rafey, M. F., Abdalgwad, R., O’Shea, P. M., Foy, S., Claffey, B., Davenport, C., O'Keeffe, D. T., & Finucane, F. M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.845574 · Cited by 10
Cruz-Pineda, W. D., Garibay‐Cerdenares, O. L., Rodríguez-Ruiz, H. A., Matia‐García, I., Marino‐Ortega, L. A., Espinoza-Rojo, M., Reyes-Castillo, Z., Castro-Alarcón, N., Castañeda-Saucedo, E., Illades‐Aguiar, B., et al. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s362881 · Cited by 10
Bartels, H. C., O’Keeffe, L. M., Yelverton, C. A., O’Neill, K., Geraghty, A. A., O’Brien, E. C., Killeen, S. L., McDonnell, C. M., & McAuliffe, F. M. (2022) · Pediatric Obesity · doi:10.1111/ijpo.12976 · Cited by 10
Snyder, L. L., Foland‐Ross, L. C., Cato, A., Reiss, A. L., Shah, C. P., Hossain, J., Elmufti, H., & Mauras, N. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13420 · Cited by 9
Cuminaldehyde ameliorates hyperglycemia in diabetic mice
Kannan, D., Pari, L., Ellappan, P., et al. (2022) · Frontiers in Bioscience-Elite · doi:10.31083/j.fbe1404024 · Cited by 10
Contribution of mitochondrial gene variants in diabetes and diabetic kidney disease
Li, M., Gong, S., Han, X., Zhou, L., Zhang, S., Ren, Q., Cai, X., Luo, Y., Liu, W., Zhu, Y., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.953631 · Cited by 12
魚谷, 奈., Noma, S., Akamine, M., & Miyawaki, T. (2022) · BioPsychoSocial Medicine · doi:10.1186/s13030-022-00251-4 · Cited by 12
Association of physical activity with metabolic profile from adolescence to adulthood
Lehtovirta, M., Wu, F., Rovio, S., Heinonen, O. J., Laitinen, T. T., Niinikoski, H., Lagström, H., Viikari, J. S. A., Rönnemaa, T., Jula, A., et al. (2022) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14261 · Cited by 10
He, H., Zhang, L., Qiu, N., Zhou, Z.-T., Zhang, K., Li, Y., Chen, H.-B., & Xu, J.-N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1041761 · Cited by 10
Shen, Y., Zheng, Y., Su, Y., Jiang, S., Ma, X., Hu, J., Li, C., Huang, Y., Teng, Y., Bao, Y., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002337 · Cited by 10
Association of adiponectin levels with polycystic ovary syndrome among Indian women
Patil, S. (2022) · Bioinformation · doi:10.6026/97320630018864 · Cited by 10
Chen, Z., Huang, C., Zhou, Z., Zhang, Y., Xu, M., Tang, Y., Fan, L., & Feng, K. (2023) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2022.1101276 · Cited by 11
Greggianin, B. F., Marques, A. E. M., Amato, A. A., & de Lima, C. L. (2023) · Clinical Oral Investigations · doi:10.1007/s00784-023-04879-6 · Cited by 10
Okura, T., Nakamura, R., Anno, M., Ito, Y., Kitao, S., Endo, S., Taneda, N., Matsumoto, K., Shoji, K., Okura, H., et al. (2023) · Metabolism Open · doi:10.1016/j.metop.2023.100242 · Cited by 8
García-Vázquez, C., Blé‐Castillo, J. L., Arias-Córdova, Y., et al. (2023) · European Journal of Nutrition · doi:10.1007/s00394-023-03154-4 · Cited by 10
Lesani, A., Jayedi, A., Karimi, M., Djafarian, K., Barkhidarian, B., Akbarzade, Z., & Shab‐Bidar, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-34235-3 · Cited by 12
CEFALO, C. M. A., Riccio, A., Fiorentino, T. V., Succurro, E., Miceli, S., Mannino, G. C., Perticone, M., Sciacqua, A., Andreozzi, F., & Sesti, G. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad300 · Cited by 10
Wang, H., Zhao, Q., Fu, Y., Liu, Z., Zhu, Y., Wang, C., & Shen, Q. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.102797 · Cited by 11
Zhu, X., Ren, T., Xiong, Q., Lin, Z., Lin, X., & Lin, G. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3450 · Cited by 9
Clusterin is closely associated with adipose tissue insulin resistance
Wang, Y., Yu, H., Ma, X., Wang, Y., Liu, W., Zhang, H., Chen, W., Song, Y., Bao, Y., & Yang, Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3688 · Cited by 11
Rundle, M., Fiamoncini, J., Thomas, E. L., Wopereis, S., Afman, L. A., Brennan, L., Drevon, C. A., Gundersen, T. E., Daniel, H., Perez, I. G., et al. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.07.002 · Cited by 11
Hong, J. H., Moon, J. S., Seong, K., & Lim, S. K. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110872 · Cited by 11
Kaba, İ., & Aydoğdu, G. (2023) · Medical Science and Discovery · doi:10.36472/msd.v10i8.1015 · Cited by 10
Lee, H. S., Jeon, Y. E., Awa, R., Yoshino, S., & Kim, E. J. (2023) · Food & Nutrition Research · doi:10.29219/fnr.v67.9413 · Cited by 10
Serum soluble α-Klotho levels in patients with diabetic nephropathy
Lefta, R. F., & Hassan, E. A. (2023) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-023-03502-7 · Cited by 11
Sex Differences in the Skeletal Muscle Response to a High Fat, High Sucrose Diet in Rats
Hulett, N. A., Knaub, L. A., Hull, S., Pott, G. B., Peelor, R., Miller, B. F., Shankar, K., Rudolph, M. C., Reusch, J. E. B., & Scalzo, R. L. (2023) · Nutrients · doi:10.3390/nu15204438 · Cited by 10
Pan, Q., Yang, Y., Cao, H., Xu, Z., Tian, Z., Zhan, Y., Li, Z., Lu, M., Gu, F., Lu, Q., et al. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01379-6 · Cited by 10
Mathew, G. M., Nahmod, N. G., Master, L., Reichenberger, D., Rosinger, A. Y., & Chang, A. (2023) · Sleep Health · doi:10.1016/j.sleh.2023.10.006 · Cited by 11
Duraccio, K. M., Xu, Y. Y., Beebe, D. W., Lanphear, B. P., Chen, A., Braun, J. M., Kalkwarf, H. J., Cecil, K. M., & Yolton, K. A. (2023) · SLEEP · doi:10.1093/sleep/zsad318 · Cited by 10
Capra, B. T., Hudson, S., Helder, M., Laskaridou, E., Johnson, A. L., Gilmore, C., Marinik, E. L., Hedrick, V. E., Savla, J. T., David, L. A., et al. (2024) · Contemporary Clinical Trials · doi:10.1016/j.cct.2024.107427 · Cited by 10
Murai, N., Saito, N., Oka, R., Nii, S., Nishikawa, H., Suzuki, A., Kodama, E., Iida, T., Mikura, K., Imai, H., et al. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0175 · Cited by 10
Tercan, H., Cossins, B. C., van Deuren, R. C., Rutten, J. H. W., Joosten, L. A. B., Netea, M. G., Hoischen, A., Bekkering, S., & Riksen, N. P. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031665 · Cited by 11
Palermo, B. J., Wilkinson, K. S., Plante, T. B., et al. (2024) · Diabetes Care · doi:10.2337/dc23-0914 · Cited by 10
Zhou, M., Mei, L., Jing, J., Yang, Y., Cai, X., Meng, X., Jin, A., Lin, J., Li, S., Li, H., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.031723 · Cited by 10
Gao, X., Li, P., Wang, G., Li, W., Song, Z. J., Zhu, S., & Zhu, L. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000001328 · Cited by 10
Association of Gut Microbiota-Related Metabolites and Type 2 Diabetes in Two Puerto Rican Cohorts
Sawicki, C. M., Pacheco, L. S., Rivas‐Tumanyan, S., Cao, Z., Haslam, D. E., Liang, L., Tucker, K. L., JOSHIPURA, K. J., & Bhupathiraju, S. N. (2024) · Nutrients · doi:10.3390/nu16070959 · Cited by 9
HbA1c or fructosamine on evaluating glucose intolerance in children with beta- thalassemia
Mahmoud, A. A. S., El‐Hawy, M. A., Allam, E. T., et al. (2024) · Pediatric Research · doi:10.1038/s41390-024-03146-y · Cited by 10
Papakonstantinou, E., Zacharodimos, N., Georgiopoulos, G. A., Athanasaki, C., Bothou, D.-L., Tsitsou, S., Lympaki, F., Vitsou-Anastasiou, S., Papadopoulou, O. S., Delialis, D., et al. (2024) · Nutrients · doi:10.3390/nu16091331 · Cited by 12
Xiang, C., Sun, Y., Luo, Y., Xie, C., Huang, W., Jones, K. L., Horowitz, M., Sun, Z., Rayner, C. K., Ma, J., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15635 · Cited by 10
Phytoconstituents of Nymphaea rubra flowers and their anti-diabetic metabolic targets
Ishrat, N., Gupta, A., Khan, M. F., et al. (2024) · Fitoterapia · doi:10.1016/j.fitote.2024.106014 · Cited by 10
Chokami, K. K., Chokami, A. K., Cammarata, G., Piras, G., Albertelli, M., Gatto, F., Vera, L., Ferone, D., & Boschetti, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05322-4 · Cited by 11
Diagnostic Accuracy of Transient Elastography in Hepatosteatosis in Youth With Obesity
Tas, E., Sundararajan, D., Lo, J. S., Morelli, N., Garcia‐Reyes, Y., Ware, M. A., Rahat, H., Ou, X., Na, X., Sundaram, S. S., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae110 · Cited by 11
Domingues-Hajj, P. M. D. S., Gomes, P. M., Magalhães, P., & Maciel, L. M. Z. (2024) · Thyroid · doi:10.1089/thy.2024.0132 · Cited by 8
Biochemical Markers in the Prediction of Pregnancy Outcome in Gestational Diabetes Mellitus
Mandić, V., Dobrijević, Z., Robajac, D., Miljuš, G., Šunderić, M., Penezić, A., Nedić, O., Ardalić, D., Miković, Ž., Radojičić, O., et al. (2024) · Medicina · doi:10.3390/medicina60081250 · Cited by 14
Berezina, T. A., Berezin, O. O., Hoppe, U. C., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14161728 · Cited by 10
Comparison of Adiposomal Lipids between Obese and Non-Obese Individuals
Hussein, M., Mirza, I., Morsy, M., Mostafa, A., Hassan, C., Masrur, M. A., Bianco, F. M., Subbaiah, P. V., Levitan, I., & Mahmoud, A. M. (2024) · Metabolites · doi:10.3390/metabo14080464 · Cited by 13
Lumaga, R. B., Tagliamonte, S., Rosa, T. D., Valentino, V., Ercolini, D., & Vitaglione, P. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.08.015 · Cited by 10
Siwek, M., Chrobak, A. A., Sołtys, Z., Dudek, D., & Krupa, A. J. (2024) · Brain Sciences · doi:10.3390/brainsci14090890 · Cited by 10
Rigamonti, A. E., Rubino, F. M., Caroli, D., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175216 · Cited by 10
The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
Vítků, J., Varausova, A., Škodová, T., Kolátorová, L., Vosátková, M., Včelák, J., Vrbíková, J., Šimková, M., & Dušková, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179691 · Cited by 12
Sprinkles, J., Lulla, A., Hullings, A. G., Trujillo‐Gonzalez, I., Klatt, K. C., Jacobs, D. R., Shah, R. V., Murthy, V. L., Howard, A. G., Gordon‐Larsen, P., et al. (2024) · Diabetes Care · doi:10.2337/dc24-1033 · Cited by 10
Shin, J., Jo, E.-A., Woo, H. Y., Cho, A., Ko, M., Kim, S., Han, A., Ha, J., & Min, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-72025-7 · Cited by 10
Hoekstra, S. P., King, J. A., Fenton, J., Kirk, N., Willis, S. A., Phillips, S. M., Webborn, N., Tolfrey, K., den Bosch, J. D. V., & Goosey-Tolfrey, V. L. (2024) · Physiological Reports · doi:10.14814/phy2.70073 · Cited by 10
Mehta, M. M., Shah, J., & Joshi, U. (2024) · Cureus · doi:10.7759/cureus.70768 · Cited by 10
Jakobsson, J., Burtin, C., Hedlund, M., Boraxbekk, C., Westman, J., Karalija, N., Stål, P., Sandström, T., Ruttens, D., Gosker, H. R., et al. (2024) · Trials · doi:10.1186/s13063-024-08481-3 · Cited by 11
Martínez‐Montoro, J. I., Arranz‐Salas, I., Gutiérrez‐Repiso, C., García, A. M. S., Ocaña-Wilhelmi, L., Pinazo-Bandera, J. M., Fernández‐García, D., Muñoz‐Garach, A., Morales-García, D. J., García‐Cortés, M., et al. (2024) · Nutrients · doi:10.3390/nu16223857 · Cited by 10
Martínez‐Montoro, J. I., Martín‐Núñez, G. M., Gonzalez-Jimenez, A., Garrido‐Sánchez, L., Moreno‐Indias, I., & Tinahones, F. J. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05746-y · Cited by 11
Lu, Y., Baker, J. S., Ying, S., & Lu, Y. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1481200 · Cited by 13
Liang, Y., Ye, X., Pan, M., Chen, Y., Yuan, Y., & Luo, L. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03661-0 · Cited by 10
Samavarchitehrani, A., Mercantepe, F., Behnoush, A. H., & Klisic, A. N. (2025) · Diagnostics · doi:10.3390/diagnostics15040494 · Cited by 12
Zhang, B., Gu, Y., Chen, Y., Xia, W., Shao, N., Zhuang, Q., & Feng, X. (2025) · Sexual Medicine · doi:10.1093/sexmed/qfaf012 · Cited by 10
Chen, W., Luo, M., Guo, J., Wang, S., Yan, D., Feng, X., Huang, Y., Zeng, T., Shen, L., Zhang, R., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02746-0 · Cited by 13
Elsherbiny, H., Alnasser, S. M., Aref, M., Elsheikh, E., El-sayed, S. F., El-Malkey, N. F., Alqahtani, H. A., Alghamdi, A. A. A., NASSAN, M. A., Abd‐Elhafeez, H. H., et al. (2025) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-025-01092-9 · Cited by 10
Colleluori, G., Viola, V., Bathina, S., Armamento‐Villareal, R., Qualls, C., Giordano, A., & Villareal, D. T. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.05.016 · Cited by 16
Vitale, S. G., Michele, S. D., Tassi, A., Succu, C., Angioni, S. L., & Fulghesu, A. M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03251-2 · Cited by 11
Mavraganis, G., Georgiopoulos, G. A., Athanasopoulos, S., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70270 · Cited by 10
Godoy‐Matos, A. F., Bahia, L., Domingues, R. C., Tambascia, M. A., Geloneze, B., Kraemer‐Aguiar, L. G., & Bouskela, E. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02868.x · Cited by 10
Endothelial progenitor cells as a cardiometabolic risk factor marker in prediabetes
Angelidi, A. M., Melidonis, A. J., Protopsaltis, I. D., et al. (2014) · HORMONES · doi:10.1007/bf03401338 · Cited by 10
Evans, M. C., Rizwan, M. Z., & Anderson, G. M. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12330 · Cited by 10
Energy expenditure and insulin sensitivity evaluation in obese children affected by hepatosteatosis
Fintini, D., Pietrobattista, A., Morino, G. S., et al. (2012) · Pediatric Obesity · doi:10.1111/j.2047-6310.2011.00018.x · Cited by 10
Uchida, J., Iwai, T., Kuwabara, N., Machida, Y., Iguchi, T., Naganuma, T., Kumada, N., Kawashima, H., & Nakatani, T. (2011) · Transplant Immunology · doi:10.1016/j.trim.2011.02.001 · Cited by 10
Wu, J., Ye, H., Wang, Y., et al. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.06.018 · Cited by 10
Jartti, L., Rönnemaa, T., Raitakari, O. T., Hedlund, E., Hammar, N., Lassila, R., Marniemi, J., Koskenvuo, M., & Kaprio, J. A. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02018.x · Cited by 10
Association of Serum γ-Glutamyltransferase Level and Incident Prehypertension in Korean Men
Chun, H., Park, S. K., & Ryoo, J. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.11.1603 · Cited by 10
Işık, A. T., Bozoğlu, E., & Eker, D. (2011) · The journal of nutrition health & aging · doi:10.1007/s12603-011-0095-4 · Cited by 12
Genetic determinants of glucose homeostasis
Barker, A., Langenberg, C., & Wareham, N. J. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.002 · Cited by 10
Ohara, M., Maesawa, C., Takebe, N., et al. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.226.161 · Cited by 10
Forst, T. M., Weber, M. M., Mitry, M., Schöndorf, T., Forst, S., Tanis, M., Pfützner, A., & Michelson, G. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600120 · Cited by 10
Hu, M., Yang, Y., Masuda, D., Yamashita, S., & Tomlinson, B. (2015) · Disease Markers · doi:10.1155/2015/154014 · Cited by 10
Kim, Y. S., Lee, M., Lim, Y., Jang, Y., Park, H., & Lee, Y. (2013) · Nutrition · doi:10.1016/j.nut.2013.02.014 · Cited by 10
Brisson, D., Perron, P., Kahn, H. S., Gaudet, D., & Bouchard, L. (2013) · Journal of Women s Health · doi:10.1089/jwh.2012.3807 · Cited by 10
Angiographically-assessed coronary artery disease associates with HDL particle size in women.
Blackburn, P., Lemieux, I., Lamarche, B., Bergeron, J., Perron, P., Tremblay, G., Gaudet, D., & Despres, J. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.016 · Cited by 10
Shiomi, M., Kobayashi, T., Kuniyoshi, N., et al. (2012) · Pathobiology · doi:10.1159/000338767 · Cited by 10
Use of clinical scores to detect dysglycaemia in overweight or obese women
Cosson, E., Chiheb, S., Hamo-Tchatchouang, E., Nguyen, T. M., Aout, M., Banu, I., Cussac-Pillegand, C., Vicaut, É., & Valensi, P. E. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2011.11.007 · Cited by 10
Karvela, A., Gil, A. P. R., Samkinidou, E., et al. (2010) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2010.162 · Cited by 10
Panidis, D., Τζιόμαλος, Κ., Papadakis, E. P., Vosnakis, C., Betsas, G., Tsourdi, E., & Katsikis, I. (2013) · Endocrine Practice · doi:10.4158/ep13058.or · Cited by 10
Ragnarsson, Ó., Burt, M. G., Ho, K. K. Y., & Johannsson, G. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0873 · Cited by 10
Yoon, B. I., Han, K., Lee, K. W., Kwon, H., Kim, S. W., Sohn, D. W., Cho, Y., & Ha, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141720 · Cited by 10
Gupta, S. K., Kitch, D. W., Tierney, C., et al. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu003 · Cited by 10
de Luis, D. A., Conde, R., Sagrado, M. G., et al. (2010) · PubMed · Cited by 10
Singla, M. K., Mukhopadhyay, P., Pandit, K., et al. (2009) · PubMed · Cited by 10
Poor glycemic control impacts linear and non-linear dynamics of heart rate in DM type 2
Dibai, D. B., Arakelian, V. M., Mendes, R. G., Caruso, F., Júnior, J. C. B., Zangrando, K. T. L., de Oliveira, C. R., Haus, J. M., Arena, R. A., & Borghi‐Silva, A. (2015) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-869220152104150003 · Cited by 10
Foco, E. (2016) · Cited by 10
Sinha, D. P., Ahmed, S., Baneerjee, A. K., et al. (2009) · PubMed · Cited by 10
Gupta, A. K., Gupta, V., Agrawal, S. S., et al. (2010) · PubMed · Cited by 10
Silymarin improves pancreatic endocrine function in rats.
Gad, S., & ElMaddawy, Z. (2014) · Pakistan Veterinary Journal · Cited by 10
Saboori, S., Djalali, M., Rad, E. Y., Nematipour, E., Saboor-Yaraghi, A. A., Javanbakht, M. H., Eshraghian, M. R., Ramezani, A., & Koohdani, F. (2016) · PubMed Central · Cited by 10
VMP1-related autophagy induced by a fructose-rich diet in β-cells: its prevention by incretins
Maiztegui, B., Boggio, V., Román, C. L., Flores, L. E., Zotto, H. H. D., Ropolo, A., Grasso, D., Vaccaro, M. I., & Gagliardino, J. J. (2017) · Clinical Science · doi:10.1042/cs20170010 · Cited by 10
Irawati, D., Mamo, J. C. L., Clark, K., Soares, M. J., & James, A. P. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517000150 · Cited by 10
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
